A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease
- PMID: 10679792
- DOI: 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0
A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease
Abstract
To facilitate studies of the normal biology of alpha-synuclein, a member of a family of neuronal proteins of unknown function, and to elucidate the role of alpha-synuclein pathologies in neurodegenerative diseases, we generated and characterized a panel of anti-synuclein antibodies. Here we demonstrate that these antibodies recognize defined epitopes spanning the entire length of human alpha-synuclein, and that some of these antibodies also cross-react with zebra finch and rodent synucleins. Since alpha-synuclein has been reported to be a major component of Lewy bodies (LBs) in Parkinson's disease (PD), dementia with LBs and common variants of Alzheimer's disease, we performed immunohistochemical studies showing that these antibodies label numerous LBs in the PD substantia nigra, thereby localizing protein domains throughout human alpha-synuclein in LBs. Taken together, our data indicate that this panel of antibodies can be exploited to probe the normal biology of alpha-synuclein as well as the role of pathological forms of this protein in PD and related neurodegenerative synucleinopathies.
Copyright 2000 Wiley-Liss, Inc.
Similar articles
-
Alpha-synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease.Arch Neurol. 2001 Nov;58(11):1817-20. doi: 10.1001/archneur.58.11.1817. Arch Neurol. 2001. PMID: 11708989
-
Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.J Neurol. 2003 Oct;250 Suppl 3:III11-4. doi: 10.1007/s00415-003-1303-x. J Neurol. 2003. PMID: 14579119
-
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.Am J Pathol. 1998 Apr;152(4):879-84. Am J Pathol. 1998. PMID: 9546347 Free PMC article.
-
[The mechanism of Lewy body formation in Parkinson's disease].Nihon Rinsho. 2000 Oct;58(10):2022-7. Nihon Rinsho. 2000. PMID: 11068441 Review. Japanese.
-
Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia.Arch Neurol. 1998 Feb;55(2):151-2. doi: 10.1001/archneur.55.2.151. Arch Neurol. 1998. PMID: 9482355 Review. No abstract available.
Cited by
-
Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam.Am J Pathol. 2002 May;160(5):1725-31. doi: 10.1016/s0002-9440(10)61119-4. Am J Pathol. 2002. PMID: 12000724 Free PMC article.
-
Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions.Acta Neuropathol. 2008 Jul;116(1):37-46. doi: 10.1007/s00401-008-0375-1. Epub 2008 Apr 15. Acta Neuropathol. 2008. PMID: 18414880 Free PMC article.
-
Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats.J Exerc Rehabil. 2017 Feb 28;13(1):30-35. doi: 10.12965/jer.1734906.453. eCollection 2017 Feb. J Exerc Rehabil. 2017. PMID: 28349030 Free PMC article.
-
Structures of α-synuclein filaments from human brains with Lewy pathology.Nature. 2022 Oct;610(7933):791-795. doi: 10.1038/s41586-022-05319-3. Epub 2022 Sep 15. Nature. 2022. PMID: 36108674 Free PMC article.
-
Conformational templating of α-synuclein aggregates in neuronal-glial cultures.Mol Neurodegener. 2013 May 28;8:17. doi: 10.1186/1750-1326-8-17. Mol Neurodegener. 2013. PMID: 23714769 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous